编辑MSTN半胱氨酸节基元促进两广小花猪肌肉生长

doi:10.16288/j.yczz.20-222

[an error occurred while processing this directive]

Hereditas(Beijing) ›› 2021, Vol. 43 ›› Issue (3): 261-270.doi: 10.16288/j.yczz.20-222

Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs

Dingwei Peng¹(), Ruiqiang Li¹(), Wu Zeng¹(), Min Wang¹, Xuan Shi¹, Jianhua Zeng², Xiaohong Liu¹, Yaoshen Chen¹, Zuyong He¹()

¹ State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510006, China
² Guangdong YIHAO Food Co.,Ltd.,Guangzhou 510620, China;

Received:2020-07-15 Online:2021-03-16 Published:2021-02-03
Supported by:
the National Transgenic Major Program(2016ZX08006003-006);the Key R&D Program of Guangdong Province(2018B020203003)

Abstract

Abstract:

Myostatin (MSTN) is a member of the transforming growth factor-β (TGF-β) family, and functions as an inhibitor of muscle growth. Disrupting the inhibitory effect of MSTN on growth can provide an effective way to increase the muscle yield of livestock and poultry. The cysteine knot motif of TGF-β can stabilize the structure of MSTN protein and plays an important regulatory role in the biological function of MSTN. Accordingly, in this study, we used the CRISRP/Cas9 to edit the exon 3 of MSTN in the kidney cells of Liang Guang Small Spotted pig (LPKCs), in order to disrupt the cysteine knot motif of MSTN and remove the inhibitory effect of MSTN on its target genes.MSTN-edited LPKCs were obtained through fluorescence-activated cell sorting (FACS) and used as donor cells for somatic cell nuclear transfer (SCNT) to generate cloned embryos, which were then transferred to surrogate sows to finally obtain eight MSTN-edited Liang Guang Small Spotted piglets. Among them, two survived to 10 days old. Genotyping revealed that these two piglets were gene edited heterozygotes with base deletion and substitution occurred within the coding sequence of C106 and C108 at the cystine knot motif of MSTN. These changes resulted in frameshift mutations, and conversion of C106 and C108 to other amino acids. More developments of muscles were observed at the shoulders and hips of the heterozygotes of MSTN-edited Liang Guang Small Spotted pigs. H&E analysis showed that the cross-sectional area (CSA) of myofiber inMSTN-edited pigs was significantly decreased, and the number of myofiber were significantly increased. Western blot analysis showed that the disruption of C106 and C108 did not affect the expression of MSTN protein, but significantly up-regulated the expression of its target genes such as Myf5, MyoD, Myogenin and other myogenic regulatory factors. In summary, the gene-edited pig model obtained in this study did not cause complete loss of MSTN expression, and could retain other biological functions of MSTN, thereby promoting muscle growth while minimizing the potential adverse effects on complete loss of MSTN in the Liang Guang Small Spotted pigs.

Key words: MSTN, CRISPR/Cas9, Liang Guang Small Spotted pig, gene editing

Dingwei Peng, Ruiqiang Li, Wu Zeng, Min Wang, Xuan Shi, Jianhua Zeng, Xiaohong Liu, Yaoshen Chen, Zuyong He. Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs[J]. Hereditas(Beijing), 2021, 43(3): 261-270.

Figures/Tables 9

Fig. 1

Fig. 2

Fig. 3

Table 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

Fig. 8

References 19

[1]	WalkerRG, PoggioliT, KatsimpardiL, BuchananSM, OhJ, WattrusS, HeideckerB, FongYW, RubinLL, GanzP, ThompsonTB, WagersAJ, LeeRT. Biochemistry and biology of GDF11 and myostatin: similarities, differences, and questions for future investigation. Circ Res, 2016, 118(7): 1125- 1142.
[2]	McPherronAC, LawlerAM, LeeSJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 1997,387(6628):83- 90.
[3]	GrobetL, MartinLJ, PonceletD, PirottinD, BrouwersB, RiquetJ, SchoeberleinA, DunnerS, MénissierF, MassabandaJ, FriesR, HansetR, GeorgesM. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet, 1997, 17(1): 71- 74.
[4]	ClopA, MarcqF, TakedaH, PirottinD, TordoirX, BibéB, BouixJ, CaimentF, ElsenJM, EychenneF, LarzulC, LavilleE, MeishF, MilenkovicD, TobinJ, CharlierC, GeorgesM. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet, 2006, 38(7): 813- 818.
[5]	MosherDS, QuignonP, BustamanteCD, SutterNB, MellershCS, ParkerHG, OstranderEA. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet, 2007,3(5): e79.
[6]	CatipovićB. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med, 2004, 351(10): 1030- 1031.
[7]	LeeSJ, McPherronAC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA, 2001,98(16):9306- 9311.
[8]	SonstegardTS, RohrerGA, SmithTP. Myostatin maps to porcine chromosome 15 by linkage and physical analyses. Anim Genet, 1998, 29(1): 19- 22.
[9]	ThiesRS, ChenT, DaviesMV, TomkinsonKN, PearsonAA, ShakeyQA, WolfmanNM. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF- 8 receptor binding. Growth Factors, 2001,18(4):251- 259.
[10]	WolfmanMW, McPherronAC, PappanoWN, DaviesMV, SongK, TomkinsonKN, WrightJF, ZhaoL, SebaldSM, GreenspanDS, LeeSJ. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proc Natl Acad Sci USA, 2003,100(26):15842- 15846.
[11]	LeeSJ. Regulstion of muscle mass by myostatin. Annu Rev Cell Dev Biol, 2004, 20(1): 61- 86.
[12]	KambadurR, SharmaM, SmithTP, BassJJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res, 1997,7(9):910- 916.
[13]	StarckCS, Sutherland-SmithAJ. The C313Y Piedmontese mutation decreases myostatin covalent dimerisation and stability. BMC Res Notes. 2011,4:442.
[14]	WangM, HuangX, ShiX, LiuXF, ZengJH, LiuXH, ChenYS, HeZY. Editing the MSTN gene of Guangdong Small Spotted pigs by using CRISPR-Cas9 system. Guangdong Agric Sci, 2017, 44( 02): 141- 148.
	王敏, 黄翔, 石翾, 刘小凤, 曾检华, 刘小红, 陈瑶生, 何祖勇. 应用CRISPR/Cas9编辑广东小耳花猪MSTN基因. 广东农业科学, 2017, 44(2): 141- 148.
[15]	ZhangZG, ZhangXL, LiJY. The excellent breeding of Chinese pigs and its contribution to the world pig industry. J Nat Resour, 1994, 9(1): 1- 8.
	张仲葛, 张晓岚, 李锦钰. 中国猪的优良种性及其对世界养猪业的贡献. 自然资源学报, 1994, 9(1): 1- 8.
[16]	RanFA, HsuPD, WrightJ, AgarwalaV, ScottDA, ZhangF. Genome engineering using the CRISPR-Cas9 system. Nat Protoc, 2013, 8(11): 2281- 2308.
[17]	LiuXF, LiuHB, WangM, LiRQ, ZengJH, MoDL, CongPQ, LiuXH, ChenYS, HeZY. Disruption of the ZBED6 binding site in intron 3 of IGF2 by CRISPR/Cas9 leads to enhanced muscle development in Liang Guang Small Spotted pigs. Transgenic Res, 2019, 28(1): 141- 150.
[18]	QianLL, TangMX, YangJZ, WangQQ, CaiCB, JiangSW, LiHG, JiangK, GaoPF, MaDZ, ChenYX, AnXR, LiK, CuiWT. Targeted mutations in myostatin by zinc-finger nucleases result in double-muscled phenotype in Meishan pigs. Sci Rep, 2015,5:14435.
[19]	BerryC, ThomasM, LangleyB, SharmaM, KambadurR. Single cysteine to tyrosine transition inactivates the growth inhibitory function of Piedmontese myostatin. Am J Physiol Cell Physiol, 2002, 283(1): C135- 141.

Metrics

Comments

www.chinagene.cn
备案号：京ICP备09063187号

Editing the cystine knot motif of MSTN enhances muscle development of Liang Guang Small Spotted pigs

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References 19

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhong Bian, Dongping Cao, Wenshu Zhuang, Shuwei Zhang, Qiaoquan Liu, Lin Zhang. Revelation of rice molecular design breeding: the blend of tradition and modernity [J]. Hereditas(Beijing), 2023, 45(9): 718-740.
[2]	Bingzheng Wang, Chao Zhang, Jiali Zhang, Jin Sun. Conditional editing of the Drosophila melanogaster genome using single transcripts expressing Cas9 and sgRNA [J]. Hereditas(Beijing), 2023, 45(7): 593-601.
[3]	Meizhen Liu, Liren Wang, Yongmei Li, Xueyun Ma, Honghui Han, Dali Li. Generation of genetically modified rat models via the CRISPR/Cas9 technology [J]. Hereditas(Beijing), 2023, 45(1): 78-87.
[4]	Xiaojun Zhang, Kun Xu, Juncen Shen, Lu Mu, Hongrun Qian, Jieyu Cui, Baoxia Ma, Zhilong Chen, Zhiying Zhang, Zehui Wei. A CRISPR/Cas9-Gal4BD donor adapting system for enhancing homology-directed repair [J]. Hereditas(Beijing), 2022, 44(8): 708-719.
[5]	Chong Zhang, Zixuan Wei, Min Wang, Yaosheng Chen, Zuyong He. Editing MC1R in human melanoma cells by CRISPR/Cas9 and functional analysis [J]. Hereditas(Beijing), 2022, 44(7): 581-590.
[6]	Yao Liu, Xianhui Zhou, Shuhong Huang, Xiaolong Wang. Prime editing: a search and replace tool with versatile base changes [J]. Hereditas(Beijing), 2022, 44(11): 993-1008.
[7]	Yuting Han, Bowen Xu, Yutong Li, Xinyi Lu, Xizhi Dong, Yuhao Qiu, Qinyun Che, Ruibao Zhu, Li Zheng, Xiaochen Li, Xu Si, Jianquan Ni. The cutting edge of gene regulation approaches in model organism Drosophila [J]. Hereditas(Beijing), 2022, 44(1): 3-14.
[8]	Guangwu Yang, Yuan Tian. The F-box gene Ppa promotes lipid storage in Drosophila [J]. Hereditas(Beijing), 2021, 43(6): 615-622.
[9]	Na Wang, Zhilian Jia, Qiang Wu. RFX5 regulates gene expression of the Pcdhα cluster [J]. Hereditas(Beijing), 2020, 42(8): 760-774.
[10]	Guoling Li, Shanxin Yang, Zhenfang Wu, Xianwei Zhang. Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals [J]. Hereditas(Beijing), 2020, 42(7): 641-656.
[11]	Yingnan Chen, Jing Lu. Application of CRISPR/Cas9 mediated gene editing in trees [J]. Hereditas(Beijing), 2020, 42(7): 657-668.
[12]	Siyuan Liu, Guoqiang Yi, Zhonglin Tang, Bin Chen. Progress on genome-wide CRISPR/Cas9 screening for functional genes and regulatory elements [J]. Hereditas(Beijing), 2020, 42(5): 435-443.
[13]	Lianchao Tang, Feng Gu. Next-generation CRISPR-Cas for genome editing: focusing on the Cas protein and PAM [J]. Hereditas(Beijing), 2020, 42(3): 236-249.
[14]	Junxia Cao, Youliang Wang, Zhengxu Wang. Advances in precise regulation of CRISPR/Cas9 gene editing technology [J]. Hereditas(Beijing), 2020, 42(12): 1168-1177.
[15]	Liwen Bao, Yiye Zhou, Fanyi Zeng. Advances in gene therapy for β-thalassemia and hemophilia based on the CRISPR/Cas9 technology [J]. Hereditas(Beijing), 2020, 42(10): 949-964.